The risk of osteoporosis in patients with asthma

References

• Loke YK, Gilbert D, Thavarajah M, et al. Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis. BMJ Open. 2015;5(11):e008554.
   Web of Science ®Google Scholar
• Yanik B, Ayrim A, Ozol D, et al. Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids. Clinics. 2009;64(4):313–9.
   Web of Science ®Google Scholar
• Gershon AS, Guan J, Wang C, et al. Describing and quantifying asthma comorbidity: a population study. PLoS One. 2012;7(5):e34967.
   Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004;59(5):469–478.
   PubMed Web of Science ®Google Scholar
• https://ginasthma.org/wp-content/uploads/2016/05/WMS-GINA-2016-main-Pocket-Guide.pdf. 2016.
   Google Scholar
• https://www.who.int/respiratory/asthma/en/. 2019.
   Google Scholar
• Daugherty J, Lin X, Baxter R, et al. The impact of long-term systemic glucocorticoid use in severe asthma: a UK retrospective cohort analysis. J Asthma. 2018;55(6):651–658.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci (Lond). 2017;131(13):1541–1558.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis. 1993;148(4_pt_2):S1–26.
   Google Scholar
• Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100(8):1307–1317.
   PubMed Web of Science ®Google Scholar
• Baylink DJ, Wergedal JE. Bone formation by osteocytes. Am J Physiol. 1971;221(3):669–678.
   PubMedGoogle Scholar
• Rossi GA, Cerasoli F, Cazzola M. Safety of inhaled corticosteroids: room for improvement. Pulm Pharmacol Ther. 2007;20(1):23–35.
   PubMed Web of Science ®Google Scholar
• Heffler E, Madeira LNG, Ferrando M, et al. Inhaled corticosteroids safety and adverse effects in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(3):776–781.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med. 2005;257(4):374–384.
   PubMed Web of Science ®Google Scholar
• Ebeling PR, Erbas B, Hopper JL, et al. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res. 1998;13(8):1283–1289.
   PubMed Web of Science ®Google Scholar
• Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159(9):941–955.
   PubMed Web of Science ®Google Scholar
• Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56.
   PubMed Web of Science ®Google Scholar
• Society DE. http://www.endocrinology.dk/index.php/3-calcium-og-knoglemetaboliske-sygdomme/3-osteoporose. 2017.
   Google Scholar
• Langhammer A. Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis. 2009;4:365–380.
   PubMedGoogle Scholar
• Inoue D, Watanabe R, Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016;11:637–648.
   Web of Science ®Google Scholar
• Sweeney J, Patterson CC, Menzies-Gow A, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the optimum patient care research database and the british thoracic difficult asthma registry. Thorax. 2016;71(4):339–346.
   PubMed Web of Science ®Google Scholar
• Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010–2018.
   PubMed Web of Science ®Google Scholar
• Abe E, Sun L, Mechanick J, et al. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Ann N Y Acad Sci. 2007;1116(1):383–391.
   Google Scholar
• Compston JE. Risk factors for osteoporosis. Clin Endocrinol (Oxf). 1992;36(3):223–224.
   PubMed Web of Science ®Google Scholar
• Wilkins CH. Osteoporosis screening and risk management. Clin Interv Aging. 2007;2(3):389–394.
   Web of Science ®Google Scholar
• Jorres RA, Welte T, Bals R, et al. Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET. Dtsch Med Wochenschr. 2010;135(10):446–449.
   Web of Science ®Google Scholar
• Omoigui S. The Interleukin-6 inflammation pathway from cholesterol to aging – role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immun Ageing. 2007;4(1):1.
   Google Scholar
• Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002;122(6):1949–1955.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Bhardwaj R, Madabhavi I, et al. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:5–21.
   PubMed Web of Science ®Google Scholar
• Theoleyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15(6):457–475.
   PubMed Web of Science ®Google Scholar
• Jimenez-Ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015;46(1):61–79.
   PubMed Web of Science ®Google Scholar
• Boulet L-P, Catherine L, Francine A, et al. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest. 2006;129(3):661–668.
   PubMed Web of Science ®Google Scholar
• Chalmers GW, MacLeod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120(6):1917–1922.
   PubMed Web of Science ®Google Scholar
• Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41(3):716–726.
   PubMed Web of Science ®Google Scholar
• Strine TW, Balluz LS, Ford ES. The associations between smoking, physical inactivity, obesity, and asthma severity in the general US population. J Asthma. 2007;44(8):651–658.
   PubMed Web of Science ®Google Scholar
• Stanescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 1996;51(3):267–271.
   PubMed Web of Science ®Google Scholar
• Cassim R, Russell MA, Lodge CJ, et al. The role of circulating 25 hydroxyvitamin D in asthma: a systematic review. Allergy. 2015;70(4):339–354.
   Web of Science ®Google Scholar
• Jat KR, Khairwa A. Vitamin D and asthma in children: a systematic review and meta-analysis of observational studies. Lung India. 2017;34(4):355–363.
   Web of Science ®Google Scholar
• Di Rosa M, Malaguarnera G, De Gregorio C, et al. Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol. 2012;280(1):36–43.
   Web of Science ®Google Scholar
• Lan N, Luo GY, Yang XQ, et al. 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. Plos One. 2014;9(11):11.
   Web of Science ®Google Scholar
• Sposato B, Scalese M, Petruzzelli L, et al. Could a vitamin D deficiency cause a combined long-term FEV1 and bone mineral density deterioration in female asthmatics? Clin Ter. 2017;168(6):E388–E91.
   Web of Science ®Google Scholar
• Janssens W, Mathieu C, Boonen S, et al. Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. Vitam Horm. 2011;86:379–399.
   PubMed Web of Science ®Google Scholar
• Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20(3):345–357.
   PubMed Web of Science ®Google Scholar
• Kokturk N, Baha A, Oh Y-M, et al. Vitamin D deficiency: what does it mean for chronic obstructive pulmonary disease (COPD)? a comprehensive review for pulmonologists. Clin Respir J. 2018;12(2):382–397.
   PubMed Web of Science ®Google Scholar
• MM R. Patients with asthma have reduced functional capacity and sedentary behavior. J Pediatr (Rio J). 2018;96(1):53–59.
   Web of Science ®Google Scholar
• Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int. 2014;2014:965764.
   PubMed Web of Science ®Google Scholar
• Canalis E, Mazziotti G, Giustina A, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18(10):1319–1328.
   PubMed Web of Science ®Google Scholar
• Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol. 2010;6(2):82–88.
   PubMed Web of Science ®Google Scholar
• Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2015;80(3):372–380.
   PubMed Web of Science ®Google Scholar
• Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immun. 2011;128(3):439–448.
   PubMed Web of Science ®Google Scholar
• Buehring B, Viswanathan R, Binkley N, et al. Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol. 2013;132(5):1019–1030.
   PubMed Web of Science ®Google Scholar
• https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf. 2018.
   Google Scholar
• Sivri A, Coplu L. Effect of the long-term use of inhaled corticosteroids on bone mineral density in asthmatic women. Respirology. 2001;6(2):131–134.
   Google Scholar
• Sambrook P, Birmingham J, Kempler S, et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990;5(12):1211–1216.
   Web of Science ®Google Scholar
• Van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39(12):1383–1389.
   PubMed Web of Science ®Google Scholar
• Van Staa TP, Staa TPV, Staa TPV. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13(10):777–787.
   PubMed Web of Science ®Google Scholar
• Van Staa TP, Laan RF, Barton IP, et al. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheumatism. 2003;48(11):3224–3229.
   PubMed Web of Science ®Google Scholar
• Mori H, Tanaka H, Ohno Y, et al. Effect of intermittent systemic corticosteroid on bone metabolism in bronchial asthma patients. J Asthma. 2009;46(2):142–146.
   PubMed Web of Science ®Google Scholar
• Packe GE, Douglas JG, Mcdonald AF, et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax. 1992;47(6):414–417.
   Web of Science ®Google Scholar
• Matsumoto H, Ishihara K, Hasegawa T, et al. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients - A 4-year longitudinal study. Chest. 2001;120(5):1468–1473.
   Web of Science ®Google Scholar
• Luengo M, Del Rio L, Pons F, et al. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J. 1997;10(9):2110–2113.
   PubMed Web of Science ®Google Scholar
• Godschalk MF, Downs RW. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res. 1988;3(1):113–115.
   PubMed Web of Science ®Google Scholar
• Dovio A, Perazzolo L, Osella G, et al. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab. 2004;89(10):4923–4928.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998;157(3):S1–53.
   PubMed Web of Science ®Google Scholar
• Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol. 1991;40(1):77–82.
   PubMed Web of Science ®Google Scholar
• Casale TB, Nelson HS, Stricker WE, et al. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol. 2001;87(5):379–385.
   PubMed Web of Science ®Google Scholar
• Laatikainen AK, Kroger HP, Tukiainen HO, et al. Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study. Am J Respir Crit Care Med. 1999;159(4):1179–1185.
   Web of Science ®Google Scholar
• Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res. 2001;16(4):782–787.
   Web of Science ®Google Scholar
• Wong CA, Walsh LJ, Smith CJ, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet. 2000;355(9213):1399–1403.
   Web of Science ®Google Scholar
• Tug T, Kamanli A, Tug E. Effects of long-term inhaled steroid use on bone mineral density in asthma patients. J Investig Allergol Clin Immunol. 2001;11(4):300–302.
   Web of Science ®Google Scholar
• Oh JY, Lee YS, Min KH, et al. Osteoporosis in Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome. Tuberc Respir Dis (Seoul). 2018;81(1):73–79.
   Web of Science ®Google Scholar
• Hubbard R, Tattersfield A, Smith C, et al. Use of inhaled corticosteroids and the risk of fracture. Chest. 2006;130(4):1082–1088.
   PubMed Web of Science ®Google Scholar
• Melton LJ 3rd, Patel A, Achenbach SJ, et al. Long-term fracture risk following adult-onset asthma: a population-based study. Osteoporos Int. 2004;15(4):311–316.
   Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest. 2007;132(5):1599–1607.
   PubMed Web of Science ®Google Scholar
• Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S, et al. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf. 2008;31(5):409–414.
   PubMed Web of Science ®Google Scholar
• Lee TA, Weiss KB. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(7):855–859.
   PubMed Web of Science ®Google Scholar
• Suissa S, Baltzan M, Kremer R, et al. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med. 2004;169(1):83–88.
   PubMed Web of Science ®Google Scholar
• Loke YK, Cavallazzi R, Singh S. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax. 2011;66(8):699–708.
   PubMed Web of Science ®Google Scholar
• Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315(7112):841–846.
   PubMed Web of Science ®Google Scholar
• Van Staa T-P, Bishop N, Leufkens HGM, et al. Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporos Int. 2004;15(10):785–791.
   Web of Science ®Google Scholar